320,859 Shares in McKesson Co. (NYSE:MCK) Acquired by Leigh Baldwin & CO. LLC

Leigh Baldwin & CO. LLC acquired a new position in shares of McKesson Co. (NYSE:MCK - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 320,859 shares of the company's stock, valued at approximately $182,861,000. McKesson accounts for about 1.0% of Leigh Baldwin & CO. LLC's holdings, making the stock its 26th largest holding. Leigh Baldwin & CO. LLC owned 0.25% of McKesson at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. ST Germain D J Co. Inc. boosted its holdings in McKesson by 350.0% in the 4th quarter. ST Germain D J Co. Inc. now owns 117 shares of the company's stock valued at $67,000 after purchasing an additional 91 shares during the period. Graypoint LLC boosted its holdings in McKesson by 3.9% in the 4th quarter. Graypoint LLC now owns 1,006 shares of the company's stock valued at $573,000 after purchasing an additional 38 shares during the period. Czech National Bank boosted its holdings in McKesson by 4.2% in the 4th quarter. Czech National Bank now owns 27,524 shares of the company's stock valued at $15,686,000 after purchasing an additional 1,108 shares during the period. Brookstone Capital Management boosted its holdings in McKesson by 42.8% in the 4th quarter. Brookstone Capital Management now owns 10,473 shares of the company's stock valued at $5,969,000 after purchasing an additional 3,137 shares during the period. Finally, Capital Investment Advisors LLC boosted its holdings in McKesson by 29.0% in the 4th quarter. Capital Investment Advisors LLC now owns 2,379 shares of the company's stock valued at $1,356,000 after purchasing an additional 535 shares during the period. 85.07% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Evercore ISI increased their price objective on shares of McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research note on Thursday, February 6th. Wells Fargo & Company increased their price objective on shares of McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a research note on Friday, March 14th. Bank of America increased their price objective on shares of McKesson from $755.00 to $800.00 and gave the company a "buy" rating in a research note on Friday, May 9th. StockNews.com upgraded shares of McKesson from a "buy" rating to a "strong-buy" rating in a research note on Tuesday. Finally, Mizuho increased their price objective on shares of McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research note on Thursday, April 3rd. Three investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $686.69.

McKesson Stock Performance

MCK traded up $16.29 during midday trading on Friday, hitting $723.05. The company had a trading volume of 1,087,990 shares, compared to its average volume of 915,647. The company has a market capitalization of $90.62 billion, a PE ratio of 33.11, a P/E/G ratio of 1.29 and a beta of 0.53. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $728.48. The firm's 50-day simple moving average is $683.14 and its 200-day simple moving average is $626.73.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.83 by $0.29. The firm had revenue of $90.82 billion during the quarter, compared to analysts' expectations of $94 billion. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The company's quarterly revenue was up 18.9% compared to the same quarter last year. During the same quarter last year, the company posted $6.18 EPS. As a group, sell-side analysts anticipate that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be given a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 0.39%. The ex-dividend date is Monday, June 2nd. McKesson's payout ratio is presently 10.99%.

Insider Buying and Selling at McKesson

In other news, CEO Brian S. Tyler sold 8,961 shares of the firm's stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the transaction, the chief executive officer now owns 60,664 shares of the company's stock, valued at approximately $36,276,465.36. This trade represents a 12.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.11% of the company's stock.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.